Top news from AHA Hypertension: Trends in BP control, hypertension in COVID-19 and more
Healio and Cardiology Today have compiled a list of the top-read news from the American Heart Association Hypertension Scientific Sessions.
Our readers were most interested in recent trends in uncontrolled BP, the impact of hypertension in COVID-19 and more.
BP control in US dropped more than 11% from 2013 to 2018
Between 2013 and 2018, the number of patients with hypertension who had their BP under control dropped more than 11%, researchers reported. Read more
Hypertension may affect outcomes in COVID-19
The most prevalent comorbidity in patients hospitalized for COVID-19 was hypertension, which was also a risk factor for acute kidney injury in the ED and mortality in these patients, researchers found in two separate studies. Read more
Mixed beliefs, practices affect hypertension diagnoses
Many providers do not follow guidelines to diagnose hypertension, including using the old clinical BP threshold of 140/90 mm Hg instead of the new threshold of 130/80 mm Hg, researchers found. Read more
AI may detect CVD with the help of gut microbiome bacteria
Researchers have developed a machine learning model using gut microbiome data sets for the diagnostic screening of CVD. Read more
Greater leg adiposity may reduce hypertension risk
A greater proportion of leg adiposity was inversely and independently linked to all subtypes of hypertension in young and middle-aged adults, researchers found. Read more
Intensive BP-lowering treatment does not raise risk for orthostatic hypotension
An intensive BP-lowering strategy did not increase risk for extreme drops in BP and should not be avoided due to preexisting orthostatic hypotension, researchers reported. Read more
Collapse
Healio Coverage
